KR20170134831A - Cosmetic composition containing extract of acer takesimense nakai as an active ingredient - Google Patents

Abstract

The present invention relates to a cosmetic composition containing an extract of Acer takesimense as an active ingredient, and more particularly, to a cosmetic composition capable of exhibiting anti-oxidant, whitening, anti-aging or wrinkle-reducing effects by using the extract of Acer takesimense as an active ingredient.

Description

COSMETIC COMPOSITION CONTAINING EXTRACT OF ACER TAKESIMENSE NAKAI AS AN ACTIVE INGREDIENT [0002]

The present invention relates to a cosmetic composition comprising an extract of an Island maple tree as an active ingredient and more particularly to a cosmetic composition which can exhibit antioxidant, whitening, anti-aging or wrinkle- .

Acer takesimense Nakai is a deciduous arboreous tree with a dicotyledonous tree, and grows up to 8 to 10 meters in height. It is a Korean specialty plant native to Korea, such as Ulleung County, Gyeongsangbuk-do, Wando, Daejuksan Island and Jeju Island.

The island maple is similar to maple, but the leaves are different in 13 (or 14) pieces. The leaves are round and round, 10 cm long, 12 cm wide, lobe lanceolate, There is no surface, but the surface is green, but the edge is reddish, the back is light color, there are no hairs on both sides, or there is hairs in the back vein. The petiole is 35 to 73 mm long, reddish, with hairs at the end, but gradually disappears. Flowers bloom at the end of branches in May, and the fruit is similar to the narrow leaves in the poem, and mature in October.

Examples of maple and similar plants that are similar to island maple are, for example, Chinese maple leaves, monolithic leaves, internal maple leaves, baby maple leaves, four islands maple leaves, Maple trees, mountain maple trees and sugar maple trees. Among them, Sugar Maple, which is the origin of North America, is famous for extracting sugar from sap and making maple syrup. However, domestic maple tree is not economical for sap and is only used for horticulture and gardening.

In addition, it is disclosed in Korean Patent Publication No. 10-2014-0077632 that an extract obtained from a dolomite which is similar to an island maple but has an anti-inflammatory effect is effective for the extract of an Island maple, however, , There is no case where the extract of maple tree is used as an active ingredient in a cosmetic composition.

Korean Patent Publication No. 10-2014-0077632

Accordingly, an object of the present invention to solve such problems is to provide a cosmetic composition comprising an extract of an Island maple tree as an active ingredient, which can exhibit antioxidant, whitening, anti-aging, or anti-wrinkle effect.

However, the problems to be solved by the present invention are not limited to the above-mentioned problems, and other problems not mentioned can be clearly understood by those skilled in the art from the following description.

In order to accomplish the above object, the present invention provides a cosmetic composition comprising an extract of maple tree as an active ingredient.

The island maple extract may be included in an amount of about 0.0025 wt% to about 0.01 wt%.

The above-mentioned maple tree extract may have antioxidative, whitening, anti-aging or wrinkle-reducing effects.

The cosmetic composition may be one or more formulations selected from the group consisting of softening water, nutritional lotion, essence, and nutritional cream.

The cosmetic composition comprising the maple extract of the present invention as an active ingredient can exhibit antioxidative, whitening, antiaging or anti-wrinkle effects by containing an extract of an Island maple.

FIG. 1 is a graph showing the DPPH (2,2-Diphenyl-1-picrylhydrazyl) scavenging activity.
FIG. 2 is a graph showing SOD (superoxide dismutase) -like activity of an extract of Island maple, according to an embodiment of the present invention.
FIG. 3 is a graph showing the results of inhibition of melanin production by the maple tree extract according to an embodiment of the present invention.
FIG. 4 is a graph showing the results of measurement of nitrogen monoxide production by an extract of an Island maple, according to an embodiment of the present invention.
FIG. 5 is a graph showing the results of an ultraviolet ray restoration test of an extract of an Island maple tree according to an embodiment of the present invention.

Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings, which will be readily apparent to those skilled in the art. The present invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. In order to clearly illustrate the present invention, parts not related to the description are omitted, and similar parts are denoted by like reference characters throughout the specification.

It is to be understood that the terms or words used in the specification and claims are not to be construed in a conventional or dictionary sense and that the inventor may properly define the concept of a term in order to best describe its invention And should be construed in accordance with the principles and meanings and concepts consistent with the technical idea of the present invention.

In the specification of the present invention, when a component is referred to as "comprising ", it means that it can include other components as well as other components, .

In the specification of the present invention, "A and / or B" means A or B, or A and B.

Hereinafter, the present invention has been specifically described with reference to the accompanying drawings, but the present invention is not limited thereto.

The present invention provides a cosmetic composition comprising an extract of an Island maple as an active ingredient.

Island maple is a Korean specialty plant that grows only in Korea. It is similar to the one in Korea but it is divided into 14 or 13 parts. It is known to drink sap by drinking before and after the spring.

In general, cosmetics are used to protect the skin and clean the hair. However, some chemical ingredients used in cosmetics, external harmful stimuli such as bacterial infection, ultraviolet rays, etc. are known to cause skin troubles such as inflammation on the skin. Accordingly, the present inventors have long studied a cosmetic composition containing a natural extract, which is not a chemical ingredient, as an effective ingredient, and found that an extract of an Island maple has skin antioxidant, whitening, anti-aging, or wrinkle- , And a maple extract containing an island maple extract as an active ingredient.

The antioxidant activity refers to an action of inhibiting the aging process, which oxidizes lipids, proteins, polysaccharides and nucleic acids, which are major constituents of the skin, as a result, promotes the aging process of skin cells and tissues. The aging process involves radicals such as superoxide radicals (O ₂ ^- ), hydroxyl radicals (OH), and hydrogen radicals (H ₂ O ₂ ) generated in vivo by metabolic reactions, ultraviolet rays, The skin is subject to oxidative stress and the antioxidant defense membrane is destroyed, thereby damaging the cells and accelerating the aging of the skin. In order to prevent skin aging, it is necessary to prevent skin damage by eliminating free radicals caused by various causes, and already damaged cells need to regenerate and proliferate through active metabolism.

Skin pigment is synthesized in Melanosome in pigmented cell called melanocyte of human skin. The process of melanin synthesis in melanocytes is based on tyrosine, a type of amino acid in the cell, and acts as an enzyme called tyrosinase. At this time, it is oxidized to DOPA (3,4-dihydroxy-phenylalanine) or DOPA quinone, and is synthesized as melanin which is a black polymer by polymerization reaction with protein or its constituent amino acid through non-enzymatic reaction and autoxidation process. Therefore, as the causes and mechanisms of melanin production are revealed, it is possible to reduce the production of melanin by mixing substances having inhibitory activity of tyrosinase, an enzyme involved in melanin production, in cosmetics or inhibiting some of the reactions during melanin production Is commonly used.

In addition, the cosmetic composition comprising an extract of an Island maple tree according to the present invention as an active ingredient has an anti-inflammatory effect due to inhibition of NO production and further has an anti-aging effect due to inflammation inhibition.

In most of the cells that make up the skin, the biosynthesis of Cox-2, cyclooxygenase, an enzyme that produces proinflammatory cytokines, which are known to cause inflammation, increases, and these inflammatory factors It is known that the biosynthesis of Matrix metalloproteinase (MMP), an enzymes that degrade skin tissue, is increased and nitric oxide (NO) production by iNOS (inducible nitric oxide synthase) is increased. Damage to cells and connective tissues by proteolytic enzymes caused by excessive inflammation and damage of connective tissues not only causes skin wrinkles, but also causes wrinkles and further aging of skin. Therefore, by inhibiting the proteins and enzymes produced by hyperinflammation, it is possible to protect the damaged cells thereby inhibiting skin aging.

Ultraviolet rays are divided into UVA (320 nm to 340 nm), UVB (280 nm to 320 nm) and UVC (200 nm to 280 nm) depending on the wavelength, And the wavelengths directly reaching the skin are UVA and UVB. Among them, UVA penetrates deeply into the dermis layer, which is the major cause of damaging fibroblasts that produce collagen that maintains skin elasticity. It activates free radicals in the skin, destroying the antioxidant defense network in vivo and damaging cells and tissues At this time, lipids, proteins, polysaccharides, etc., which are major constituents of the skin, are oxidized. Among them, the oxidation of proteins breaks down the connective tissues like collagen and, in severe cases, it induces cancer or triggers immunosuppression. Activation of free radicals in vivo accelerates the degradation of extracellular matrix by increasing matrix metalloproteinase (MMP), an enzyme that degrades collagen by reactive oxygen, resulting in reduced skin elasticity and wrinkles.

 The island maple extract may be included in the cosmetic composition at about 0.0025% to about 0.01% by weight. If the content of the maple tree extract is less than 0.0025% by weight, antioxidation, whitening, anti-aging or wrinkle-improving effect by the maple tree extract may not be expected. If the content of the maple tree extract is more than 0.01% by weight Toxicity of the extract of the maple tree can be expressed.

The content of the island maple extracts relative to the total weight of the cosmetic composition is about 0.0025 wt% to about 0.01 wt%, about 0.0025 wt% to about 0.0075 wt%, about 0.0025 wt% to about 0.005 wt%, about 0.005 wt% to about 0.01 %, From about 0.0075% to about 0.01%, or from about 0.005% to about 0.0075% by weight of the composition.

The cosmetic composition may be one or more formulations selected from the group consisting of softening water, nutritional lotion, essence, and nutritional cream. Specifically, the cosmetic composition containing the maple extract of the present invention as an active ingredient can be used for cosmetics, cleansers and shampoos for one or more uses selected from the group consisting of antioxidation, whitening, antiaging and wrinkle improvement. Examples of the products to which the maple extract can be added include cosmetics such as various creams, lotions, lotions, lotions, essences, packs, powders, lipsticks, foundations, shampoos, rinses, treatments, soaps, have.

The cosmetic composition comprising an extract of an Island maple tree as an active ingredient according to an embodiment of the present invention may contain at least one selected from the group consisting of a fat component, a moisturizer, an emollient, a surfactant, a pigment, an ultraviolet absorber, an antiseptic, an antioxidant, , Perfumes, and the like.

Hereinafter, the present invention will be described in more detail with reference to Examples. However, the following Examples are given for the purpose of helping understanding of the present invention, but the present invention is not limited to the following Examples.

[Example]

Example 1. Evaluation of antioxidative effect

1-1. DPPH (2,2-Diphenyl-1-picrylhydrazyl) scavenging activity experiment

In order to measure the DPPH scavenging effect on maple extract (from the National Institute of Biological Resources Wildlife Natural Products), the extract of maple tree was diluted in purified water to determine its antioxidative effect. 50 μg / ml, 25 μg / ml), and L-ascorbic acid (100 μg / ml) was used as a control.

To measure the electron donating ability of each sample, 100 μl of 5 × 10 ^-4 M DPPH was added to 100 μl of each concentration solution, and the mixture was stirred for 1 minute. After incubation in a 25 ° C incubator for 30 minutes, the absorbance at 540 nm was measured using a microplate reader. FIG. 1 shows the results of antioxidant activity test by DPPH scavenging ability of the maple tree extract according to the present invention, showing a DPPH scavenging effect of 85% or more at a concentration of 100 μg / ml of the extract of the maple tree of the present invention.

1-2. Superoxide dismutase (SOD) -like activity experiment

The SOD-like activity of the maple extract of the present invention was measured as follows.

200 ㎕ of WST working solution in SOD assay kit (WST) was added to 20 ㎕ of sample extract solution of each leaf extract (concentration: 110 ㎍ / ㎖, 1 ㎍ / ㎖, 0.1 μg / ml), and 20 μl of the enzyme working solution was added thereto, followed by reaction at 37 ° C. for 20 minutes in an incubator. The absorbance at 450 nm was measured using a microplate counter. SOD-like activity was used as an experimental control, and the SOD-like activity was expressed as the absorbance reduction rate of the sample solution and the non-added sample. The results are shown in FIG. 2, and the SOD-like activity of 99% or more was exhibited at a concentration of 10 μg / ml of the maple extract of the present invention.

Example 2. Evaluation of whitening effect

2-1. Cytotoxicity test

Neutral red assay method was used for cytotoxicity test. Cells were cultured in 96-well plates at a concentration of 5 × 10 ⁴ cells / ml for 24 hours. The cells were incubated with 1% Antibiotic-Antimycotic (100X, Gibco) and 10% B16F1 melanoma, And cultured in a 5% CO 2 incubator at 37 ° C using DMEM (Dulbecco's modified essential medium, Hyclone) containing FBS (Fetal bovine serum, Gibco). After the incubation, the samples were treated. At this time, the maple extract was dissolved in DMSO (dimethyl sulfoxide, Wako) and diluted to the extraction solvent according to each experimental method. After the culture was completed, the plate was treated with Neutral Red and incubated for 2 hours. Then, the solution was removed, and the plate was washed with 1 wt% CaCl 2 and 1 wt% formaldehyde solution for 1 min. Then, the solution was removed and 1 wt% And 1% by weight formaldehyde solution were added and reacted for 5 minutes, and the absorbance at 570 nm was measured using a microplate counter.

The results of the cytotoxicity evaluation by the concentration of the maple extract of the present invention are shown in Table 1 below.

Concentration (/ / ml)   Cell survival rate (%) 100 96.49 75 102.9 50 103.2 25 108.1 10 102.5 5 96.7 One 96.4 0.1 91.2 0.01 97.5

As a result of the cytotoxicity test of the above Table 1, the extract of Iseki maple showed no cytotoxicity at a concentration of 100 μg / ml (= 100 ppm = 0.01% by weight) or less.

2-2. Measurement of inhibition of melanin formation

B16F1 melanoma cells were cultured in a 6-well plate at a concentration of 5 × 10 ⁴ cells / ml for 24 hours, and then the above-mentioned concentration of the sample was added to the culture medium of B16F1 melanoma cell as a test substance and cultured for 3 days. At this time, 0.2 μM of α-MSH (Melanicyte stimulating hormone) was treated with the intention to induce melanin synthesis, and arbutin, a well known inhibitor of melanin synthesis, And used as a control.

After culturing for 48 hours, the culture medium was removed, washed twice with PBS (phosphate buffered saline), treated with trypsin for 5 minutes, transferred to an ep-tube, washed with PBS, dried with 1N NaOH And 10% DMSO solution, and transferred to a 96-well plate. The absorbance at 490 nm was measured using a microplate counter. FIG. 3 is a graph showing the results of inhibition of melanin formation by the extract of the maple tree according to the present invention. As a result, when the absorbance values were compared with a blank treated with? -MSH and a control group treated with? -MSH , and the control group treated with α-MSH produced about 1.6 times more melanin.

In addition, when compared to α-MSH-treated arbutin (500 μg / ml), the extract of Island maple significantly inhibited melanogenesis even at a lower concentration (100 μg / ml) than arbutin. Thus, the effect of inhibiting the melanin formation of the maple extract of the present invention was confirmed.

Example  3. Evaluation of anti-aging effect

3-1. Cell viability measurement

The cytotoxicity test was carried out by the MTT assay method.

100 쨉 l of mouse macrophages (Raw 264.7 cells) were dispensed in a 96-well plate at a concentration of 5 × 10 ⁴ cells / ml and cultured in a CO ₂ incubator at 37 ° C for 16 hours. At this time, the medium was DMEM medium containing 10% bovine serum and 1% antibiotic. After the culture, the medium was replaced with DMEM medium in which bovine serum and antibiotics were excluded. The samples were added at different concentrations and incubated for 24 hours under the same incubation conditions. After the incubation, 5 ㎎ / ㎖ MTT (Thiazolyl Blue Tetrazolium Bromide) reagent was added and incubated for 3 hours under the same conditions. After removing the culture medium, 100 μl of DMSO was added, shaking for 20 minutes, and the result was measured at 570 nm using a microplate counter.

The results of measurement of cell viability according to the concentration of the maple extract of the present invention are shown in Table 2 below.

Concentration (/ / ml) Cell proliferation rate (%) 100 113.6 75 112.9 50 117.4 25 109.4 10 108.1 5 99.3 One 93.6 0.1 90.4 0.01 84.4

As a result of the cytotoxicity test in the above Table 2, the extract of Is maple showed no cytotoxicity at a concentration of 100 μg / ml or less.

3-2. Assessment of NO production using grease analysis method

100 쨉 l of mouse macrophages (Raw 264.7 cells) were dispensed in a 96-well plate at a concentration of 5 × 10 ⁵ cells / ml and cultured in a CO ₂ incubator at 37 ° C for 24 hours. At this time, the medium was DMEM medium containing 10% bovine serum and 1% antibiotic. After the culture, the medium was replaced with a separate DMEM medium containing 10% of bovine serum and 1% of antibiotics. Then, the maple leaf extract was added to each concentration and incubated for 30 minutes under the same culture conditions. Then, 1 μg / 1 μl of LPS (lipopolysaccharide) was added and cultured for 24 hours to induce inflammation in mouse macrophages. Griess reagent I and II were mixed in the same amount after the induction of inflammation, and 50 μl of the resulting mixture was placed in a 96-well plate, followed by reaction in an incubator at 37 ° C for 10 minutes. Was used to measure the result at 540 nm. The blanks were replaced with the separate DMEM medium containing 10% bovine serum and 1% antibiotics, and then incubated for the same period of time as the experimental group without treatment with the extract of maple and LPS, .

The LPS is known to be endotoxin and is present in the extracellular membrane of Gram-negative bacteria. TNF-α, IL-6, IL-1β (Interleukin- Lt; RTI ID = 0.0 > 1beta). ≪ / RTI > When inflammatory stimuli such as LPS are given from outside, it is known that I-κB kinase is activated and decomposed, and heterodimer is activated, and it moves into the nucleus to promote gene expression of cytokine, iNOS, which induces an inflammatory reaction.

FIG. 4 is a graph showing the results of nitrogen monoxide production by the maple tree extract according to the present invention. As a result, a low NO production amount (μM) at a concentration of 100 μg / .

NO acts as a chemical mediator in inflammation. It is produced by inducible nitric oxide synthase (iNOS) and accumulates in the body, causing pain to the body. By inhibiting the activity of iNOS, nitric oxide Is suppressed.

Example 4 Evaluation of ultraviolet ray recovery effect

4-1. Cell viability measurement

The cytotoxicity test was carried out by the MTT assay method.

Human fibroblasts were cultured in a CO ₂ incubator at 37 ° C in order to examine the cytotoxicity against the maple extract of the islets. After culturing, the maple extracts were treated at different concentrations and then further cultured under the same culture conditions. After the incubation, MTT solution was added and incubated. After that, the culture solution was removed, DMSO was added, the mixture was shaken appropriately, and the absorbance was measured using a Michael Plate counter.

Table 3 shows the results of cell viability measurement by concentration of maple extract of the present invention.

Concentration (/ / ml) Cell proliferation rate (%) 100 123.6 75 114.5 50 101.5 25 92.5 10 92.8 5 96.5

As a result of the cytotoxicity test of the above Table 3, the extract of Iseki maple did not show cytotoxicity at a concentration of 100 μg / ml or less.

4-2. Ultraviolet light recovery effect

Human fibroblasts were cultured in a CO ₂ incubator at a concentration of 5 × 10 ⁴ cells / ml at 37 ° C. After that, the culture medium was removed, washed with PBS, irradiated with ultraviolet rays (UVA) using a UV irradiator system with PBS, treated with the maple leaf extract at each concentration, Lt; / RTI > After incubation, solution was added and incubated at 37 ℃. After the culture was removed, DMSO was added, shaken appropriately, and the absorbance was measured using a microplate counter. EGCG (Epigallocatechin gallate) at a concentration of 10 μM was used as a positive control for comparison of test results. The blank was washed with PBS, and incubated for the same time as the experimental group without the UV irradiation and the treatment with the maple extract. As a negative control group, UVA irradiation was carried out under the same culture conditions and treated with the solution for the same time without any treatment.

FIG. 5 is a graph showing the results of an ultraviolet ray-restoring effect of the maple tree extract according to the present invention. At 100 ㎍ / ㎖ of maple extract extract, EGCG showed higher UV activity than EGCG.

Prescription Example 1. Preparation of softening longevity formulation

A long-acting softening formulation containing an extract of the maple tree as an active ingredient was prepared.

More specifically, sodium hyaluronate was dispersed in purified water in a propeller mixer at 3000 rpm to prepare a concentration of 1 wt%. Raw materials 1 to 8 were homogenized at a speed of 500 rpm using a propeller mixer, heated to 75 ° C to be completely dissolved, and then cooled to room temperature. Ingredients Nos. 9 to 11 were completely dissolved and prepared in a separate dissolution tank, and the mixture was added to the above-mentioned water dissolution tank and mixed by stirring. Here, the island maple extract was added, and the mixture was thoroughly stirred to prepare a softener.

Raw material ingredient Content (% by weight) One Island maple extract 0.01 2 Polyoxyethylene hardened castor oil 0.5 3 Glycine 3.0 4 Dipotassium glycyrrhizate 0.1 5 1,3-butylene glycol 3.0 6 Sodium hyaluronate 1.0 7 ethanol 5.0 8 Antioxidant 0.1 9 Triethanolamine 0.1 10 EDTA 0.1 11 Purified water Balance

Prescription example  2. Production of nutritional lotion formulations

A nutritional lotion formulation containing an extract of maple tree as an active ingredient was prepared.

In Table 5, the carbomer was dispersed in purified water using a propeller mixer at a speed of 4000 rpm to prepare a solution containing 2% by weight. Raw materials 1 to 6 were put into an aqua-melting tank and dispersed by stirring at a speed of 2000 rpm using a homomixer, and then heated to 75 ° C. The raw materials 7 to 14 were added to the oily melting tank and dissolved by heating to 75 ° C. The oil phase dissolved in the water-soluble solubilization tank was charged and emulsified (3000 rpm / 5 minutes) and then cooled to room temperature. The extract of maple tree was added to the mixture, and the mixture was thoroughly stirred to prepare a nutrition lotion.

Raw material ingredient Content (% by weight) One Island maple extract 0.01 2 glycerin 7.0 3 Sorbitan stearate
Sucrose cocoate 2.0 4 Mineral oil 4.0 5 Trioctanoin 1.0 6 Stearic acid 1.0 7 Glyceryl stearate 0.5 8 Sorbitan monostearate 1.0 9 Dimethicone 0.5 10 Antioxidant 0.3 11 Triethanolamine 0.1 12 Carbomer 2.0 13 EDTA 0.1 14 Purified water Balance

Prescription example  3. Preparation of essence formulation

An essence formulation containing an extract of maple tree as an active ingredient was prepared.

Specifically, in Table 4, sodium hyaluronate and hydroxyethylcellulose were each dispersed in purified water at a rate of 2000 rpm using a propeller mixer to prepare a solution containing 1% by weight. The carbomer was prepared by dispersing the purified water in a propeller mixer at a speed of 4000 rpm to prepare a solution containing 2% by weight. Raw materials 1 to 12 were fed into an aqua yard, stirred and dispersed at a speed of 2000 rpm using a homomixer, and then heated to 75 캜. The warmed water phase was cooled to room temperature. The ingredients 13 to 15 were completely dissolved in a separate dissolution tank, and the mixture was added to the above-mentioned water dissolution tank and mixed by stirring. The extract of the maple tree of the present invention was added thereto and sufficiently stirred to prepare an essence.

Raw material ingredient Content (% by weight) One Island maple extract 0.01 2 glycerin 5.0 3 1,3-butylene glycol 2.0 4 Polyethylene glycol 2.0 5 Carbomer 1.0 6 Sodium hyaluronate 0.1 7 Glycine 3.0 8 Polyacrylamide 2.0 9 Hydroxyethylcellulose 0.2 10 ethanol 3.0 11 Antioxidant 0.3 12 Triethanolamine 0.1 13 Polyoxyethylene hardened castor oil 1.0 14 EDTA 0.1 15 Purified water Balance

Prescription example  4. Manufacture of nutritional cream formulations

A nutritional cream formulation containing an extract of maple tree as an active ingredient was prepared.

Specifically, as shown in Table 7 below, raw materials 1 to 8 were fed into an aqua-melting bath and dispersed by stirring at a speed of 2000 rpm using a homo, and then heated to 75 캜. Ingredients 9 to 16 were added to an oily melting tank and dissolved by heating to 80 ° C. The oil phase dissolved in the water-soluble solubilization tank was charged and emulsified (3000 rpm / 10 minutes) and then cooled to room temperature. The extract of maple tree was added to the mixture, and the mixture was thoroughly stirred to prepare nutritional cream.

Raw material ingredient Content (% by weight) One Island maple extract 0.01 2 1,3-butylene glycol 3.0 3 glycerin 3.0 4 Hydrogenated lecithin 1.0 5 Octyldodecanol 3.0 6 Trioctanoin 2.0 7 Stearic acid 1.5 8 Cetostearyl alcohol 2.0 9 Polysorbate 60 1.5 10 Sorbitan sesquioleate 2.0 11 Dimethicone 3.0 12 Antioxidant 0.3 13 Xanthan gum 0.2 14 Triethanolamine 0.1 15 EDTA 0.1 16 Purified water Balance

It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit or scope of the present invention. You will understand. It is therefore to be understood that the embodiments described above are illustrative in all aspects and not restrictive. For example, each component described as a single entity may be distributed and implemented, and components described as being distributed may also be implemented in a combined form.

The scope of the present invention is defined by the appended claims rather than the detailed description and all changes or modifications derived from the meaning and scope of the claims and their equivalents are to be construed as being included within the scope of the present invention do.

Claims (4)

A cosmetic composition comprising an extract of maple tree as an active ingredient.
The method according to claim 1,
Wherein said maple extract is contained in an amount of 0.0025 to 0.01% by weight.
The method according to claim 1,
Wherein said maple extract has antioxidant, whitening, anti-aging or wrinkle-improving effect.
The method according to claim 1,
Wherein the cosmetic composition is used as one or more formulations selected from the group consisting of softening water, nutritional lotion, essence and nutritional cream.

Images